Difference between revisions of "Antimicrobial prophylaxis"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "www.ncbi.nlm.nih.gov/pubmed" to "pubmed.ncbi.nlm.nih.gov") |
m |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
=Guidelines= | =Guidelines= | ||
| + | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.''' | ||
==ASCO/IDSA== | ==ASCO/IDSA== | ||
| − | * '''2018:''' Taplitz et al. [https:// | + | * '''2018:''' Taplitz et al. [https://doi.org/10.1200/JCO.18.00374 Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update] [https://pubmed.ncbi.nlm.nih.gov/30179565/ PubMed] |
| − | * '''2018:''' Taplitz et al. [https:// | + | * '''2018:''' Taplitz et al. [https://doi.org/10.1200/JCO.2017.77.6211 Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update] [https://pubmed.ncbi.nlm.nih.gov/29461916/ PubMed] |
| − | + | * '''2013:''' Flowers et al. [https://doi.org/10.1200/JCO.2012.45.8661 Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline] [https://pubmed.ncbi.nlm.nih.gov/23319691/ PubMed] | |
| − | |||
| − | * '''2013:''' Flowers et al. [https:// | ||
[[Category:Clinical pharmacology]] | [[Category:Clinical pharmacology]] | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
Latest revision as of 14:30, 1 February 2024
This is a stub page that will be expanded over time
Guidelines
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
ASCO/IDSA
- 2018: Taplitz et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update PubMed
- 2018: Taplitz et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update PubMed
- 2013: Flowers et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline PubMed